These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19759006)

  • 1. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A.
    Cekic C; Casella CR; Eaves CA; Matsuzawa A; Ichijo H; Mitchell TC
    J Biol Chem; 2009 Nov; 284(46):31982-91. PubMed ID: 19759006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4.
    Cekic C; Casella CR; Sag D; Antignano F; Kolb J; Suttles J; Hughes MR; Krystal G; Mitchell TC
    J Immunol; 2011 Apr; 186(7):3858-65. PubMed ID: 21339365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.
    Watts BA; Tamayo E; Sherwood ER; Good DW
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F705-F719. PubMed ID: 31241993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes.
    Hernandez A; Bohannon JK; Luan L; Fensterheim BA; Guo Y; Patil NK; McAdams C; Wang J; Sherwood ER
    J Leukoc Biol; 2016 Dec; 100(6):1311-1322. PubMed ID: 27354411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.
    Watts BA; George T; Sherwood ER; Good DW
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F103-F115. PubMed ID: 28356284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A.
    Stark RJ; Choi H; Koch SR; Fensterheim BA; Lamb FS; Sherwood ER
    Clin Sci (Lond); 2016 Mar; 130(6):451-61. PubMed ID: 26669797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inefficient TLR4/MD-2 heterotetramerization by monophosphoryl lipid A.
    Casella CR; Mitchell TC
    PLoS One; 2013; 8(4):e62622. PubMed ID: 23638128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
    Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
    Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells.
    Kolanowski ST; Lissenberg-Thunnissen SN; Emal D; van Ham SM; Ten Brinke A
    Inflamm Res; 2016 Jun; 65(6):449-58. PubMed ID: 26994069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
    Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
    Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
    Embry CA; Franchi L; Nuñez G; Mitchell TC
    Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
    Bowen WS; Minns LA; Johnson DA; Mitchell TC; Hutton MM; Evans JT
    Sci Signal; 2012 Feb; 5(211):ra13. PubMed ID: 22337809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS.
    Stark R; Choi H; Koch S; Lamb F; Sherwood E
    Innate Immun; 2015 Aug; 21(6):565-74. PubMed ID: 25540284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways.
    George PJ; Marches R; Nehar-Belaid D; Banchereau J; Lustigman S
    Front Immunol; 2022; 13():961094. PubMed ID: 36119026
    [No Abstract]   [Full Text] [Related]  

  • 15. TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells.
    Sun X; Hosomi K; Shimoyama A; Yoshii K; Lan H; Wang Y; Yamaura H; Nagatake T; Ishii KJ; Akira S; Kiyono H; Fukase K; Kunisawa J
    Int Immunopharmacol; 2023 Apr; 117():109852. PubMed ID: 36806039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
    Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
    Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
    Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
    Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
    Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
    Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells.
    Dyevoich AM; Disher NS; Haro MA; Haas KM
    Cancer Immunol Immunother; 2020 Oct; 69(10):2113-2124. PubMed ID: 32448982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.